Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bendetowicz, A. V.
Right arrow Articles by Kaufman, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bendetowicz, A. V.
Right arrow Articles by Kaufman, R. J.
Related Collections
Right arrow Hemostasis, Thrombosis, and Vascular Biology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Binding of Factor VIII to von Willebrand Factor Is Enabled by Cleavage of the von Willebrand Factor Propeptide and Enhanced by Formation of Disulfide-Linked Multimers

Ana Victoria Bendetowicz, Jill A. Morris, Robert J. Wise, Gary E. Gilbert, and Randal J. Kaufman

From the Brockton/West Roxbury VAMC, West Roxbury, MA; the Brigham and Women's Hospital, Boston, MA; the Harvard University Medical School, Boston, MA; the Department of Biological Chemistry and the Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI.

von Willebrand factor (vWF) is a multimeric adhesive glycoprotein with one factor VIII binding site/subunit. Prior reports suggest that posttranslational modifications of vWF, including formation of N-terminal intersubunit disulfide bonds and subsequent cleavage of the propeptide, influence availability and/or affinity of factor VIII binding sites. We found that deletion of the vWF propeptide produced a dimeric vWF molecule lacking N-terminal intersubunit disulfide bonds. This molecule bound fluorescein-labeled factor VIII with sixfold lower affinity than multimeric vWF in an equilibrium flow cytometry assay (approximate KDs, 5 nmol/L v 0.9 nmol/L). Coexpression of propeptide-deleted vWF with the vWF propeptide in trans yielded multimeric vWF that displayed increased affinity for factor VIII. Insertion of an alanine residue at the N-terminus of the mature vWF subunit destroyed binding to factor VIII, indicating that the native mature N-terminus is required for factor VIII binding. The requirement for vWF propeptide cleavage was shown by (1) a point mutation of the vWF propeptide cleavage site yielding pro-vWF that was defective in factor VIII binding and (2) correlation between efficiency of intracellular propeptide cleavage and factor VIII binding. Furthermore, in a cell-free system, addition of the propeptide-cleaving enzyme PACE/furin enabled factor VIII binding in parallel with propeptide cleavage. Our results indicate that high-affinity factor VIII binding sites are located on N-terminal disulfide-linked vWF subunits from which the propeptide has been cleaved.

Blood, Vol. 92 No. 2 (July 15), 1998: pp. 529-538
© 1998 by the American Society of Hematology.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
CLIN APPL THROMB HEMOSTHome page
A. Casonato, E. Pontara, F. Sartorello, M.G. Cattini, P. Perutelli, A. Bertomoro, L. Gallinaro, and A. Pagnan
Identifying Carriers of Type 2N von Willebrand Disease: Procedures and Significance
Clinical and Applied Thrombosis/Hemostasis, April 1, 2007; 13(2): 194 - 200.
[Abstract] [PDF]


Home page
BloodHome page
A. Casonato, F. Sartorello, M. G. Cattini, E. Pontara, C. Soldera, A. Bertomoro, and A. Girolami
An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant
Blood, January 1, 2003; 101(1): 151 - 156.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. E. Gilbert, R. J. Kaufman, A. A. Arena, H. Miao, and S. W. Pipe
Four Hydrophobic Amino Acids of the Factor VIII C2 Domain Are Constituents of Both the Membrane-binding and von Willebrand Factor-binding Motifs
J. Biol. Chem., February 15, 2002; 277(8): 6374 - 6381.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. L. Haberichter, S. A. Fahs, and R. R. Montgomery
Von Willebrand factor storage and multimerization: 2 independent intracellular processes
Blood, September 1, 2000; 96(5): 1808 - 1815.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P.L. Turecek, L. Pichler, W. Auer, G. Eder, K. Varadi, A. Mitterer, W. Mundt, U. Schlokat, F. Dorner, L.O. Drouet, et al.
Evidence for Extracellular Processing of Pro-von Willebrand Factor After Infusion in Animals With and Without Severe von Willebrand Disease
Blood, September 1, 1999; 94(5): 1637 - 1647.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. V. Bendetowicz, R. J. Wise, and G. E. Gilbert
Collagen-bound von Willebrand Factor Has Reduced Affinity for Factor VIII
J. Biol. Chem., April 30, 1999; 274(18): 12300 - 12307.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. J. Kaufman, A. J. Dorner, and D. N. Fass
von Willebrand Factor Elevates Plasma Factor VIII Without Induction of Factor VIII Messenger RNA in the Liver
Blood, January 1, 1999; 93(1): 193 - 197.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 1998 by American Society of Hematology         Online ISSN: 1528-0020